Rapid Micro Biosystems (NASDAQ:RPID) Raised to “Hold” at Wall Street Zen

Rapid Micro Biosystems (NASDAQ:RPID) was upgraded by Wall Street Zen from a “sell” rating to a “hold” rating in a research note issued to investors on Saturday.

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Rapid Micro Biosystems in a report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat, Rapid Micro Biosystems currently has an average rating of “Moderate Buy” and an average price target of $8.00.

Rapid Micro Biosystems Price Performance

Shares of NASDAQ RPID opened at $3.15 on Friday. Rapid Micro Biosystems has a 52 week low of $0.87 and a 52 week high of $4.50. The business’s 50 day moving average price is $3.54 and its 200 day moving average price is $3.36. The company has a quick ratio of 2.95, a current ratio of 4.23 and a debt-to-equity ratio of 0.42. The firm has a market cap of $139.61 million, a P/E ratio of -3.12 and a beta of 1.33.

Rapid Micro Biosystems (NASDAQ:RPID) last posted its quarterly earnings results on Friday, November 7th. The company reported ($0.26) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.26). The company had revenue of $7.84 million during the quarter, compared to analyst estimates of $7.60 million. Rapid Micro Biosystems had a negative net margin of 145.11% and a negative return on equity of 73.90%. On average, sell-side analysts expect that Rapid Micro Biosystems will post -1.1 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in RPID. Geode Capital Management LLC raised its position in shares of Rapid Micro Biosystems by 1.6% in the second quarter. Geode Capital Management LLC now owns 204,079 shares of the company’s stock worth $704,000 after acquiring an additional 3,143 shares during the period. American Century Companies Inc. raised its holdings in Rapid Micro Biosystems by 46.1% in the 2nd quarter. American Century Companies Inc. now owns 16,922 shares of the company’s stock worth $58,000 after purchasing an additional 5,341 shares during the period. Susquehanna International Group LLP raised its holdings in Rapid Micro Biosystems by 12.6% in the 3rd quarter. Susquehanna International Group LLP now owns 58,387 shares of the company’s stock worth $195,000 after purchasing an additional 6,528 shares during the period. Hudson Bay Capital Management LP acquired a new stake in Rapid Micro Biosystems in the third quarter valued at approximately $38,000. Finally, Dimensional Fund Advisors LP increased its position in shares of Rapid Micro Biosystems by 37.8% in the third quarter. Dimensional Fund Advisors LP now owns 55,642 shares of the company’s stock valued at $186,000 after buying an additional 15,255 shares in the last quarter. Hedge funds and other institutional investors own 52.60% of the company’s stock.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems (NASDAQ: RPID) develops and commercializes automated microbial detection and contamination control solutions for the life sciences industry. Its flagship offering, the Growth Direct® System, leverages digital imaging and proprietary growth indicator plates to identify and count microorganisms more rapidly than traditional culture-based methods. The company’s technology platform is designed to streamline quality control workflows in pharmaceutical, biotechnology and vaccine manufacturing settings, helping clients reduce release times and improve operational efficiency.

In addition to the Growth Direct® System, Rapid Micro Biosystems offers an integrated suite of software and consumables that support automated data capture, analysis and reporting.